Weill Cornell Medicine Awarded $11.3M Grant for Prostate Cancer Research September 7, 2017 Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to improve detection, diagnosis and treatment of prostate cancer – a disease that affects one in six men.Read more.Source: Weill Cornell Medicine Prostate Cancer News
Weill Cornell Medicine has been awarded a five-year, $11.3 million Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to improve detection, diagnosis and treatment of prostate cancer – a disease that affects one in six men.Read more.Source: Weill Cornell Medicine
